These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. cDNA arrays and the enigma of melanoma immune responsiveness. Wang E; Marincola FM Cancer J; 2001; 7(1):16-24. PubMed ID: 11269643 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma. Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911 [TBL] [Abstract][Full Text] [Related]
13. Signatures of microRNAs and selected microRNA target genes in human melanoma. Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of primary cutaneous melanoma. Winnepenninckx V; Van den Oord JJ Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873 [TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. Cheng SL; Liu RH; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ J Biomed Sci; 2007 Jan; 14(1):87-105. PubMed ID: 17103032 [TBL] [Abstract][Full Text] [Related]
16. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. Busam KJ; Zhao H; Coit DG; Kucukgol D; Jungbluth AA; Nobrega J; Viale A J Invest Dermatol; 2005 Feb; 124(2):412-8. PubMed ID: 15675962 [TBL] [Abstract][Full Text] [Related]